In fact, high levels of RARα, RARβ, RXRα and RXRβ are associated with unfavorable prognostic clinical and pathological characteristics of gastric cancer, such as stage-IV and “de novo” metastatic disease. This evidence concerns the gene RXRA and metastatic neoplasm.